Cargando…
StemRegenin 1 selectively promotes expansion of Multipotent Hematopoietic Progenitors derived from Human Embryonic Stem Cells
Human embryonic stem cell (hESC)-derived hematopoietic stem/progenitor cells hold tremendous potential as alternative cell sources for the treatment of various hematological diseases, drug discovery and toxicological screening. However, limited number of hematopoietic stem/progenitor cells generated...
Autores principales: | Tao, Lihong, Togarrati, Padma Priya, Choi, Kyung-Dal, Suknuntha, Kran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Stem Cells and Regenerative Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786649/ https://www.ncbi.nlm.nih.gov/pubmed/29391752 |
Ejemplares similares
-
StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells
por: Hwang, You Jung, et al.
Publicado: (2023) -
Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG)
por: Dahlberg, Ann, et al.
Publicado: (2014) -
StemRegenin-1 Attenuates Endothelial Progenitor Cell Senescence by Regulating the AhR Pathway-Mediated CYP1A1 and ROS Generation
por: Lim, Hye Ji, et al.
Publicado: (2023) -
Reducing TGF‐β1 cooperated with StemRegenin 1 promoted the expansion ex vivo of cord blood CD34(+) cells by inhibiting AhR signalling
por: Zhu, Xuejun, et al.
Publicado: (2021) -
Identification of Multipotent Progenitors that Emerge Prior to Hematopoietic Stem Cells in Embryonic Development
por: Inlay, Matthew A., et al.
Publicado: (2014)